retatrutide trials dosing Dosage & Guide: Titration, Missed Doses, Taper Dosing Schedule for Retatrutide: Trial

We hear a lot about these acute side effects, like gastrointestinal distress

Lococo et al., 2017)

JAMA Internal Medicine publishes a clinical study regarding patients with liver disease and diabetes on GLP-1 drugs, demonstrating a lower risk of progression to cirrhosis and mortality

Backlash and a fuzzy future Murmurs of a backlash against the escalated approval of GLP-1s in India went beyond social media, to the Indian judiciary in 2025 long predating the Indian governments official guidelines for the usage of these drugs, which came out in the first week of April

The primary concern with showering is not the medications effectiveness, but rather the comfort and cleanliness of the skin itself